Pioneering Efforts Produce Regenerative Products
May 29, 2015
Tissue Regenix Wound Care Inc.
Diabetic patients suffering diabetic foot ulcers (wounds) are benefiting from pioneering efforts in wound therapy. Tissue Regenix, an international medical technology company is leading the development of a range of regenerative products to make specialized replacement tissue using biological (human & animal) materials.
The company offers an expanding roster of products based on their patented dCELL® decellularization technology to provide acellular tissue scaffolds which are not rejected by the patient’s body. DermaPure® is a new decellularized human dermis product from Tissue Regenix used by physicians to help promote wound healing. Initial clinical use has demonstrated that DermaPure® allografts may have scaffold characteristics – including elasticity, porosity and bio-compatibility – comparable to natural tissue, which have been shown to promote beneficial cellular activity during healing.
Cats, the record-breaking musical spectacular by Andrew Lloyd Webber that has captivated audiences in over 30 countries and 15 languages, is now on tour across North America!
From Broadway to cooking and health, stay tuned for another jam-packed episode of The Balancing Act.
Last month, we sat down with Laura Kronen, who shared her experience with managing diabetes. She's back to give us an update on life with Eversense.